Cargando…
Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study
BACKGROUND: Use of drugs with anticholinergic properties (DAP) has a negative impact on older people. OBJECTIVE: Our aim was to examine the association between DAP at hospital admission and mortality in older patients. PATIENTS AND METHODS: We performed a nationwide population-based cohort study inc...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844340/ https://www.ncbi.nlm.nih.gov/pubmed/34414558 http://dx.doi.org/10.1007/s40801-021-00270-7 |
_version_ | 1784651451993161728 |
---|---|
author | Sørensen, Søren Ramsdal Frederiksen, Jeppe Dalskov Anru, Pavithra Laxsen Masud, Tahir Petrovic, Mirko Rosholm, Jens-Ulrik Ryg, Jesper |
author_facet | Sørensen, Søren Ramsdal Frederiksen, Jeppe Dalskov Anru, Pavithra Laxsen Masud, Tahir Petrovic, Mirko Rosholm, Jens-Ulrik Ryg, Jesper |
author_sort | Sørensen, Søren Ramsdal |
collection | PubMed |
description | BACKGROUND: Use of drugs with anticholinergic properties (DAP) has a negative impact on older people. OBJECTIVE: Our aim was to examine the association between DAP at hospital admission and mortality in older patients. PATIENTS AND METHODS: We performed a nationwide population-based cohort study including patients aged ≥ 65 years admitted to Danish geriatric medicine departments during 2005–2014. National health registers were used to link with individual-level data. Patients were followed to emigration, death, or study termination (31 December 2015). DAP was defined as medications included in the anticholinergic cognitive burden (ACB) scale, which assigns each DAP a score between 1 and 3. The individual ACB score was calculated and the number of DAP counted. We used Cox proportional-hazard regressions to estimate the crude and adjusted hazard ratios adjusting for age, activities of daily living, marital status, index admission period, BMI, and prior hospitalizations (model 1), and additionally Charlson Comorbidity Index (model 2). RESULTS: We included 74,589 patients aged (median [IQR]) 83 (77–88) years. Use of one or more DAP (62.5%) was associated with increased mortality compared with those with no use (p < 0.001). In the fully adjusted model 2, compared with no use, higher mortality risks (HR [95% CI]) were seen with ACB score of 2 and number of DAP ≥ 5 for 30-day (1.46 [1.32–1.61] and 1.46 [1.09–1.95]), 1-year (1.34 [1.28–1.41] and 1.48 [1.29–1.70]), and overall mortality (1.27 [1.23–1.31] and 1.44 [1.31–1.59]), respectively. CONCLUSIONS: Use of DAP at hospital admission is associated with short- and long-term mortality in geriatric patients. Deprescribing studies are warranted to study whether the impact on mortality can be attenuated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40801-021-00270-7. |
format | Online Article Text |
id | pubmed-8844340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-88443402022-02-23 Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study Sørensen, Søren Ramsdal Frederiksen, Jeppe Dalskov Anru, Pavithra Laxsen Masud, Tahir Petrovic, Mirko Rosholm, Jens-Ulrik Ryg, Jesper Drugs Real World Outcomes Original Research Article BACKGROUND: Use of drugs with anticholinergic properties (DAP) has a negative impact on older people. OBJECTIVE: Our aim was to examine the association between DAP at hospital admission and mortality in older patients. PATIENTS AND METHODS: We performed a nationwide population-based cohort study including patients aged ≥ 65 years admitted to Danish geriatric medicine departments during 2005–2014. National health registers were used to link with individual-level data. Patients were followed to emigration, death, or study termination (31 December 2015). DAP was defined as medications included in the anticholinergic cognitive burden (ACB) scale, which assigns each DAP a score between 1 and 3. The individual ACB score was calculated and the number of DAP counted. We used Cox proportional-hazard regressions to estimate the crude and adjusted hazard ratios adjusting for age, activities of daily living, marital status, index admission period, BMI, and prior hospitalizations (model 1), and additionally Charlson Comorbidity Index (model 2). RESULTS: We included 74,589 patients aged (median [IQR]) 83 (77–88) years. Use of one or more DAP (62.5%) was associated with increased mortality compared with those with no use (p < 0.001). In the fully adjusted model 2, compared with no use, higher mortality risks (HR [95% CI]) were seen with ACB score of 2 and number of DAP ≥ 5 for 30-day (1.46 [1.32–1.61] and 1.46 [1.09–1.95]), 1-year (1.34 [1.28–1.41] and 1.48 [1.29–1.70]), and overall mortality (1.27 [1.23–1.31] and 1.44 [1.31–1.59]), respectively. CONCLUSIONS: Use of DAP at hospital admission is associated with short- and long-term mortality in geriatric patients. Deprescribing studies are warranted to study whether the impact on mortality can be attenuated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40801-021-00270-7. Springer International Publishing 2021-08-19 /pmc/articles/PMC8844340/ /pubmed/34414558 http://dx.doi.org/10.1007/s40801-021-00270-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Article Sørensen, Søren Ramsdal Frederiksen, Jeppe Dalskov Anru, Pavithra Laxsen Masud, Tahir Petrovic, Mirko Rosholm, Jens-Ulrik Ryg, Jesper Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study |
title | Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study |
title_full | Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study |
title_fullStr | Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study |
title_full_unstemmed | Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study |
title_short | Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study |
title_sort | use of drugs with anticholinergic properties at hospital admission associated with mortality in older patients: a danish nationwide register-based cohort study |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844340/ https://www.ncbi.nlm.nih.gov/pubmed/34414558 http://dx.doi.org/10.1007/s40801-021-00270-7 |
work_keys_str_mv | AT sørensensørenramsdal useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy AT frederiksenjeppedalskov useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy AT anrupavithralaxsen useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy AT masudtahir useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy AT petrovicmirko useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy AT rosholmjensulrik useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy AT rygjesper useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy |